Clinical inputs
Understand the result,
not just the number.
High Bleeding Risk Diagnosis Score Tool Explanation and Clinical Context This calculator summarizes major bleeding related factors highlighted in the twenty twenty five American Heart Association acute coronary syndrome guideline to assist clinicians in identifying patients who have elevated bleeding potential during antithrombotic therapy. The variables reflect clinical domains frequently associated with hemorrhagic events such as advanced age prior major bleeding kidney dysfunction anemia thrombocytopenia intracranial events active malignancy and use of oral anticoagulants. A total score of two or more suggests high bleeding risk and supports consideration of shorter DAPT window de escalation strategies or careful balancing of ischemic benefit against hemorrhagic harm.
This tool is intended to complement clinical judgement rather than replace individualized assessment since bleeding and ischemic risks evolve over time and patient goals comorbidity burden renal function procedural complexity and troponin profile remain critical in decision making.
- Source 1
ACC AHA ACS Clinical Practice Guideline Twenty Twenty Five. High bleeding risk considerations for ACS antithrombotic therapy. Journal of the American College of Cardiology Twenty Twenty Five. Urban P et al. Defining high bleeding risk in patients undergoing PCI. Circulation Twenty Nineteen.
Loading discussion…